Cargando…
Development of Schamberg's disease after SARS‐CoV‐2 vaccination
Schamberg's disease is one of a group of pigmented purpura diseases. We report a 43‐year‐old woman, who developed Schamberg’s disease after SARS‐CoV‐2 vaccination. Three days after vaccination, a purpuric eruption occurred on the lower extremities, extending to the buttocks, and subsided in 4 w...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347743/ http://dx.doi.org/10.1002/cia2.12247 |
_version_ | 1784761876626800640 |
---|---|
author | Morimoto, Hiroki Ogura, Yasuaki Otsuka, Masaki Hayano, Satoshi Tokura, Yoshiki |
author_facet | Morimoto, Hiroki Ogura, Yasuaki Otsuka, Masaki Hayano, Satoshi Tokura, Yoshiki |
author_sort | Morimoto, Hiroki |
collection | PubMed |
description | Schamberg's disease is one of a group of pigmented purpura diseases. We report a 43‐year‐old woman, who developed Schamberg’s disease after SARS‐CoV‐2 vaccination. Three days after vaccination, a purpuric eruption occurred on the lower extremities, extending to the buttocks, and subsided in 4 weeks. No recurrence was observed thereafter. It is suggested that the vaccination triggered the development of the eruption, which was not merely coincidental. SARS‐CoV‐2 vaccination may stimulate a certain population of T cells, resulting in the development of pigmented purpuric dermatoses.[Image: see text] |
format | Online Article Text |
id | pubmed-9347743 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93477432022-08-03 Development of Schamberg's disease after SARS‐CoV‐2 vaccination Morimoto, Hiroki Ogura, Yasuaki Otsuka, Masaki Hayano, Satoshi Tokura, Yoshiki Journal of Cutaneous Immunology and Allergy Correspondences Schamberg's disease is one of a group of pigmented purpura diseases. We report a 43‐year‐old woman, who developed Schamberg’s disease after SARS‐CoV‐2 vaccination. Three days after vaccination, a purpuric eruption occurred on the lower extremities, extending to the buttocks, and subsided in 4 weeks. No recurrence was observed thereafter. It is suggested that the vaccination triggered the development of the eruption, which was not merely coincidental. SARS‐CoV‐2 vaccination may stimulate a certain population of T cells, resulting in the development of pigmented purpuric dermatoses.[Image: see text] John Wiley and Sons Inc. 2022-05-12 /pmc/articles/PMC9347743/ http://dx.doi.org/10.1002/cia2.12247 Text en © 2022 The Authors. Journal of Cutaneous Immunology and Allergy published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society for Cutaneous Immunology and Allergy https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Correspondences Morimoto, Hiroki Ogura, Yasuaki Otsuka, Masaki Hayano, Satoshi Tokura, Yoshiki Development of Schamberg's disease after SARS‐CoV‐2 vaccination |
title | Development of Schamberg's disease after SARS‐CoV‐2 vaccination |
title_full | Development of Schamberg's disease after SARS‐CoV‐2 vaccination |
title_fullStr | Development of Schamberg's disease after SARS‐CoV‐2 vaccination |
title_full_unstemmed | Development of Schamberg's disease after SARS‐CoV‐2 vaccination |
title_short | Development of Schamberg's disease after SARS‐CoV‐2 vaccination |
title_sort | development of schamberg's disease after sars‐cov‐2 vaccination |
topic | Correspondences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347743/ http://dx.doi.org/10.1002/cia2.12247 |
work_keys_str_mv | AT morimotohiroki developmentofschambergsdiseaseaftersarscov2vaccination AT ogurayasuaki developmentofschambergsdiseaseaftersarscov2vaccination AT otsukamasaki developmentofschambergsdiseaseaftersarscov2vaccination AT hayanosatoshi developmentofschambergsdiseaseaftersarscov2vaccination AT tokurayoshiki developmentofschambergsdiseaseaftersarscov2vaccination |